COVID-19 Vaccine Trials Need to Be Based on Good Science

It is 2020 and we still have to remind the health care decision makers that data need to be collected, analyzed, and reported by race, ethnicity, and gender. The reason behind this push to have meaningful inclusion of diverse population is that it is good science; and, to not do so may have dangerous consequences. This is especially true for clinical trials as they are meant to provide information that is useful about anyone who will use it or take it. Here is our OpEd piece on COVID-19 vaccine clinical trials that appeared in The Hill.